Pharmaceutical Industry

Home
Sectors
Pharmaceutical Industry

12 March 2026

Santa Farma Passes DIGEMID GMP Inspection in Peru

Turkish pharmaceutical manufacturer Santa Farma has successfully passed a major international regulatory inspection. The company’s GEBKİM Dilovası production facility completed the GMP (Good Manufacturing Practices) audit conducted by Peru’s health authority DIGEMID with a positive assessment. The certification further strengthens Santa Farma’s regulatory standing and market access in Latin America.

12 March 2026

Dr. Sabri Öncel Appointed as New CEO

One of Türkiye’s long-established pharmaceutical companies, Drogsan Pharmaceuticals, has announced a significant leadership transition. Dr. Sabri Öncel has been appointed as the company’s new Chief Executive Officer, effective March 9, 2026. Former CEO Dr. Ersan Küçük, who led the company for 18 years, will continue contributing as a strategic advisor.

09 March 2026

Senior Appointment at AIFD: Dr. Nihan Burul Bozkurt Named Deputy Secretary General

The Association of Research-Based Pharmaceutical Companies (AIFD) has announced a key leadership appointment. Dr. Pharmacist Nihan Burul Bozkurt, who has served as Director of Health Policies since 2021, has been promoted to Deputy Secretary General of the association. In her new role, she will lead strategic health policy initiatives and manage AIFD’s relations with major global pharmaceutical organizations.

05 March 2026

Humanis Introduces New Treatment for Parkinson’s Disease Psychosis in Türkiye

Psychotic symptoms such as hallucinations and delusions may emerge as Parkinson’s disease progresses, significantly affecting patients’ quality of life. The new treatment introduced by Humanis in Türkiye aims to expand the limited therapeutic options available for Parkinson’s disease psychosis and improve outcomes for both patients and caregivers

03 March 2026

Orzax Marks World Omega-3 Day with “Blue Trace” Initiative to Combat Ghost Nets

Orzax has launched a comprehensive initiative against ghost nets threatening marine ecosystems under its “Blue Trace” project, announced as part of World Omega-3 Day on March 3. Ghost nets recovered from the seabed by professional divers have been repurposed through art to raise environmental awareness. The initiative represents a key pillar of the company’s long-term commitment to protecting marine biomass.

19 February 2026

Santa Farma Reaches a New Milestone in Its Global Journey with TURQUALITY Support Program

Santa Farma, one of Türkiye’s long-established pharmaceutical companies, has been included in the TURQUALITY Support Program, aiming to further strengthen its competitiveness in international markets.

16 February 2026

Collagen Types (Type 1, 2, 3): Which Supplement is Best for Skin, and Which for Joints?

We examine the distinct roles of collagen types on the skin and joints, identifying which supplement addresses which biological goal, and the technical details of raw material sources that determine absorption rates.

23 January 2026

A New Standard for Pharma Packaging

New requirements are making packaging more functional, with a focus on stronger protection and lower environmental impact. Digital labeling is emerging as a key tool for traceability and transparency.

15 January 2026

İKMİB Pharmaceutical Committee Kicks Off 2026 With Institutional Visits

The Pharmaceutical Committee of the Istanbul Chemicals and Chemical Products Exporters’ Association (İKMİB) has launched its 2026 agenda with a series of institutional visits. The initiative aims to strengthen cooperation in line with export targets by assessing the sector’s priorities on site.

13 January 2026

Santa Farma and MEALIS Expand Strategic Partnership, Rights to Iron Sucrose Drug Transferred to MEALIS

Santa Farma Pharmaceuticals has expanded its strategic collaboration with MEALIS Middle East Life Sciences, transferring the sales, marketing, and distribution rights of its iron sucrose complex product to MEALIS. The agreement will take effect on December 11, 2025.

13 January 2026

NVIDIA and Lilly Launch Joint AI Innovation Lab to Transform Drug Discovery

NVIDIA and Eli Lilly have announced the launch of a joint AI innovation lab aimed at reshaping drug discovery in the age of artificial intelligence. The two companies plan to invest up to $1 billion over five years to accelerate AI-driven research and development.

12 January 2026

Experimental Drug Reduced Brain Damage in Alzheimer’s Model Mice

In a study led by Case Western Reserve University, an experimental compound was found to improve cognitive performance and reduce signs of brain damage in mice modeling Alzheimer’s disease. The findings raise the possibility that some effects of the disease could be reversible, rather than only slowed.

‹ 1 2 3 ›

Double Victory for Tadelle and Sarelle at the Business Honors Awards

McDonald’s Türkiye and TBWA\Istanbul Subvert Tradition

Ülker and TBF Ink Comprehensive Partnership: Strategic Three-Year Support for Turkish Basketball

Bepanthol® Derma Unveils New "Expert Face Care" Range

Liquid Supplement Revolution: 59% of Consumers Shift to Beverage Formats

Mercedes-Benz Celebrates 140th Anniversary on Eastern Express: New Electric GLC Debuts in Turkey

Double Victory for Tadelle and Sarelle at the Business Honors Awards

Kerry Group Selects Form Endüstri Ürünleri for High-Efficiency HVAC and Process Cooling Infrastructure

McDonald’s Türkiye and TBWA\Istanbul Subvert Tradition

The Intersection of Contemporary Art and Bespoke Engineering: Rolls-Royce Unveils Cyril Kongo Signed Black Badge Cullinan Series

Paintistanbul 2026: Turkish Paint Industry Sets Sights on Global Leadership

SkinCeuticals Merges Science and Art: Cellular Transformation via "Floating Matter II"

Ülker and TBF Ink Comprehensive Partnership: Strategic Three-Year Support for Turkish Basketball

Advertise with ChemEx World